Introducción. “Esclerodermia” significa “piel dura”. El término. “esclerodermia localizada” como diagnóstico principal se refiere al hecho de que las. vol número4 Aplicación del Examen Clínico Objetivo Estructurado en la residencia de Pediatría de la Ciudad de Buenos Angiomas venosos y cefalea en . Morfea o esclerodermia localizada juvenil, descripción de caso clínico y actualización. 9. Arkachaisri T, Vilaiyuk S, Li S, O’Neill KM, Pope E, Higgins.
|Published (Last):||17 November 2009|
|PDF File Size:||16.87 Mb|
|ePub File Size:||2.25 Mb|
|Price:||Free* [*Free Regsitration Required]|
Early diagnosis, appropriate assessment and effective treatment are crucial to improve the long-term outcome.
The esclerodremia is presented of an 8 year-old girl who presented with indurated hypopigmented plaques, of linear distribution in the right upper extremity of two years onset, together with papery texture hyperpigmented indurated plaques with whitish areas of thinned skin in right lower extremity, and leg and ankle swelling.
In juvenile localized scleroderma JLSnew techniques such as Doppler and laser Doppler imaging have shown their usefulness for the daily monitoring of the patients. The clinical features and escledodermia tests, including histology were compatible with linear and pansclerotic JLS.
Finally, a randomized, double-blind controlled trial, a multicenter consensus statement and long-term follow-up studies have confirmed the important role of methotrexate MTX for the treatment of JLS. New developments have been also reached in the field of outcome measures. Pediatrla started with immunosuppressive therapy, physiotherapy, and occupational therapy. Recent studies, concerning histopathology and clinical associations with other conditions, open new horizons on the etiopathogenesis of scleroderma.
Scleroderma in children: an update.
Morphea or juvenile localised scleroderma JLS is an autoimmune, inflammatory, chronic, slowly progressive connective tissue disease of unknown cause that preferably affects skin and underlying tissues. To report a case of Juvenil Localised scleroderma in an 8-year old girl, contributing to an early diagnosis and treatment. We report a case of linear and pansclerotic ELJ esclrrodermia, in which there was a 2 year delay in diagnosis, however the response to treatment was positive as expected.
In juvenile systemic sclerosis JSSca new severity score has been developed and needs to be validated in future trials. escelrodermia
Morphea; Juvenile localised scleroderma; Autoimmune. Studies over recent years highlighted the role of imaging as outcome measures for JLS and introduced a severity score for JSSc. Morphea or juvenile localised scleroderma: Scleroderma, in its localized and systemic presentation, represents the third most frequent rheumatic condition in childhood after juvenile idiopathic arthritis and systemic lupus erythematosus.